Alpha-Pyrrolidinobutiophenone

From WikiMD's Food, Medicine & Wellness Encyclopedia

Alpha-Pyrrolidinobutiophenone (α-PBP) is a stimulant compound developed in the 1960s, which has been reported as a novel designer drug. It is a member of the cathinone class of psychoactive substances.

Chemistry[edit | edit source]

Alpha-Pyrrolidinobutiophenone is a synthetic cathinone, which is a type of amphetamine. It is chemically similar to other synthetic cathinones such as Mephedrone and Methylone. The chemical formula for Alpha-Pyrrolidinobutiophenone is C15H21NO. It is a white crystalline powder at room temperature.

Pharmacology[edit | edit source]

The pharmacological effects of Alpha-Pyrrolidinobutiophenone are primarily due to its action as a dopamine reuptake inhibitor. This results in increased levels of dopamine in the brain, leading to feelings of euphoria and increased energy. However, it also has the potential to cause a range of adverse effects, including tachycardia, hypertension, and potential for addiction.

Legal Status[edit | edit source]

The legal status of Alpha-Pyrrolidinobutiophenone varies by country. In many countries, including the United States, it is classified as a controlled substance due to its potential for abuse and addiction. In other countries, it may be legal for research purposes but not for human consumption.

Health Risks[edit | edit source]

The use of Alpha-Pyrrolidinobutiophenone carries significant health risks. These include cardiovascular problems such as tachycardia and hypertension, as well as neurological issues such as seizures. There is also a high risk of addiction and dependence.

See Also[edit | edit source]

Template:Psychoactive substance Template:Controlled substances Template:Designer drugs

Alpha-Pyrrolidinobutiophenone Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD